Ignite Creation Date:
2025-12-24 @ 8:03 PM
Ignite Modification Date:
2026-02-22 @ 1:33 PM
Study NCT ID:
NCT00772304
Status:
COMPLETED
Last Update Posted:
2010-03-02
First Post:
2008-10-13
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Evaluation of the Sensory Attributes of Olopatadine 0.6% and Azelastine 137mcg Nasal Sprays in Patients w/Allergic Rhinitis
Sponsor:
Alcon Research
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
SMA-08-21
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Michael Edwards, PhD\Global Scientific Market Affairs
Old Organization:
Alcon Research